Madopar HBS in fluctuating parkinsonian patients: Two‐year treatment
作者:
G. Pezzoli,
S. Tesei,
C. Ferrante,
E. Cossutta,
A. Zecchinelli,
G. Scarlato,
期刊:
Movement Disorders
(WILEY Available online 1988)
卷期:
Volume 3,
issue 1
页码: 37-45
ISSN:0885-3185
年代: 1988
DOI:10.1002/mds.870030106
出版商: Wiley Subscription Services, Inc., A Wiley Company
关键词: Parkinson's disease;Motor fluctuations;Sustained‐release levodopa
数据来源: WILEY
摘要:
AbstractIn an open‐label study, we substituted conventional levodopa plus benserazide: 100/25 (Madopar) with a controlled‐release form (HBS) in 18 fluctuating parkinsonian patients for 24 months. Significantly positive results were obtained in both peak‐dose and diphasic dyskinesias up to 12 months of treatment; morning akinesias were also improved up to 6 months. A general trend of deterioration, compared to the first 3–6 months of HBS treatment, was observed in “off” fluctuations after 1 year: akinesias due to a delayed response worsened after 1 year of treatment also when compared with the conventional treatment. Positive results were obtained with new HBS on standard Madopar‐related psychiat
点击下载:
PDF
(539KB)
返 回